1-[2-(4-acetylpiperazin-1-yl)sulfonylphenoxy]-6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxyhexan-2-one;6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxy-1-[[6-(oxan-4-ylamino)-2-pyridinyl]oxy]hexan-2-one;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(2-methyl-3,4-dihydro-1H-isoquinolin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(2-methylindazol-4-yl)oxyacetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[2-(methylsulfamoyl)phenoxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(3-oxo-4H-1,4-benzoxazin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(1,2,3,4-tetrahydroisoquinolin-8-yloxy)acetamide

C164H206N22O29S2 — CID 159917798

IUPAC1-[2-(4-acetylpiperazin-1-yl)sulfonylphenoxy]-6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxyhexan-2-one;6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxy-1-[[6-(oxan-4-ylamino)-2-pyridinyl]oxy]hexan-2-one;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(2-methyl-3,4-dihydro-1H-isoquinolin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(2-methylindazol-4-yl)oxyacetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[2-(methylsulfamoyl)phenoxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(3-oxo-4H-1,4-benzoxazin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(1,2,3,4-tetrahydroisoquinolin-8-yloxy)acetamide
SMILESCC(=O)N1CCN(S(=O)(=O)c2ccccc2OCC(=O)CCC(O)CN2CCc3ccccc3C2)CC1.CN1CCc2cccc(OCC(=O)NCC(O)CN3CCc4ccccc4C3)c2C1.CNS(=O)(=O)c1ccccc1OCC(=O)NCC(O)CN1CCc2ccccc2C1.Cn1cc2c(OCC(=O)NCC(O)CN3CCc4ccccc4C3)cccc2n1.O=C(CCC(O)CN1CCc2ccccc2C1)COc1cccc(NC2CCOCC2)n1.O=C(COc1cccc2c1CNCC2)NCC(O)CN1CCc2ccccc2C1.O=C(COc1cccc2c1OCC(=O)N2)NCC(O)CN1CCc2ccccc2C1
InChIInChI=1S/C27H35N3O6S.C25H33N3O4.C24H31N3O3.C23H29N3O3.C22H26N4O3.C22H25N3O5.C21H27N3O5S/c1-21(31)29-14-16-30(17-15-29)37(34,35)27-9-5-4-8-26(27)36-20-25(33)11-10-24(32)19-28-13-12-22-6-2-3-7-23(22)18-28;29-22(17-28-13-10-19-4-1-2-5-20(19)16-28)8-9-23(30)18-32-25-7-3-6-24(27-25)26-21-11-14-31-15-12-21;1-26-11-9-19-7-4-8-23(22(19)16-26)30-17-24(29)25-13-21(28)15-27-12-10-18-5-2-3-6-20(18)14-27;27-20(15-26-11-9-17-4-1-2-5-19(17)14-26)12-25-23(28)16-29-22-7-3-6-18-8-10-24-13-21(18)22;1-25-14-19-20(24-25)7-4-8-21(19)29-15-22(28)23-11-18(27)13-26-10-9-16-5-2-3-6-17(16)12-26;26-17(12-25-9-8-15-4-1-2-5-16(15)11-25)10-23-20(27)13-29-19-7-3-6-18-22(19)30-14-21(28)24-18;1-22-30(27,28)20-9-5-4-8-19(20)29-15-21(26)23-12-18(25)14-24-11-10-16-6-2-3-7-17(16)13-24/h2-9,24,32H,10-20H2,1H3;1-7,21-22,29H,8-18H2,(H,26,27);2-8,21,28H,9-17H2,1H3,(H,25,29);1-7,20,24,27H,8-16H2,(H,25,28);2-8,14,18,27H,9-13,15H2,1H3,(H,23,28);1-7,17,26H,8-14H2,(H,23,27)(H,24,28);2-9,18,22,25H,10-15H2,1H3,(H,23,26)
InChIKeyNXZXEEMIWYBOGQ-UHFFFAOYSA-N
MW3013.71 g/mol
LogP10.27
Rot. Bonds57

About 1-[2-(4-acetylpiperazin-1-yl)sulfonylphenoxy]-6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxyhexan-2-one;6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxy-1-[[6-(oxan-4-ylamino)-2-pyridinyl]oxy]hexan-2-one;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(2-methyl-3,4-dihydro-1H-isoquinolin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(2-methylindazol-4-yl)oxyacetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[2-(methylsulfamoyl)phenoxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(3-oxo-4H-1,4-benzoxazin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(1,2,3,4-tetrahydroisoquinolin-8-yloxy)acetamide

1-[2-(4-acetylpiperazin-1-yl)sulfonylphenoxy]-6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxyhexan-2-one;6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxy-1-[[6-(oxan-4-ylamino)-2-pyridinyl]oxy]hexan-2-one;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(2-methyl-3,4-dihydro-1H-isoquinolin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(2-methylindazol-4-yl)oxyacetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[2-(methylsulfamoyl)phenoxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(3-oxo-4H-1,4-benzoxazin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(1,2,3,4-tetrahydroisoquinolin-8-yloxy)acetamide (PubChem CID 159917798) has the molecular formula C164H206N22O29S2 and a molecular weight of 3013.71 g/mol. Its IUPAC name is 1-[2-(4-acetylpiperazin-1-yl)sulfonylphenoxy]-6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxyhexan-2-one;6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxy-1-[[6-(oxan-4-ylamino)-2-pyridinyl]oxy]hexan-2-one;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(2-methyl-3,4-dihydro-1H-isoquinolin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(2-methylindazol-4-yl)oxyacetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[2-(methylsulfamoyl)phenoxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(3-oxo-4H-1,4-benzoxazin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(1,2,3,4-tetrahydroisoquinolin-8-yloxy)acetamide.

Molecular Properties

Compound Name1-[2-(4-acetylpiperazin-1-yl)sulfonylphenoxy]-6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxyhexan-2-one;6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxy-1-[[6-(oxan-4-ylamino)-2-pyridinyl]oxy]hexan-2-one;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(2-methyl-3,4-dihydro-1H-isoquinolin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(2-methylindazol-4-yl)oxyacetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[2-(methylsulfamoyl)phenoxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(3-oxo-4H-1,4-benzoxazin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(1,2,3,4-tetrahydroisoquinolin-8-yloxy)acetamide
PubChem CID159917798
Molecular FormulaC164H206N22O29S2
Molecular Weight3013.71 g/mol
Exact Mass3011.48
IUPAC Name1-[2-(4-acetylpiperazin-1-yl)sulfonylphenoxy]-6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxyhexan-2-one;6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxy-1-[[6-(oxan-4-ylamino)-2-pyridinyl]oxy]hexan-2-one;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(2-methyl-3,4-dihydro-1H-isoquinolin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(2-methylindazol-4-yl)oxyacetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[2-(methylsulfamoyl)phenoxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(3-oxo-4H-1,4-benzoxazin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(1,2,3,4-tetrahydroisoquinolin-8-yloxy)acetamide
SMILESCC(=O)N1CCN(S(=O)(=O)c2ccccc2OCC(=O)CCC(O)CN2CCc3ccccc3C2)CC1.CN1CCc2cccc(OCC(=O)NCC(O)CN3CCc4ccccc4C3)c2C1.CNS(=O)(=O)c1ccccc1OCC(=O)NCC(O)CN1CCc2ccccc2C1.Cn1cc2c(OCC(=O)NCC(O)CN3CCc4ccccc4C3)cccc2n1.O=C(CCC(O)CN1CCc2ccccc2C1)COc1cccc(NC2CCOCC2)n1.O=C(COc1cccc2c1CNCC2)NCC(O)CN1CCc2ccccc2C1.O=C(COc1cccc2c1OCC(=O)N2)NCC(O)CN1CCc2ccccc2C1
InChIInChI=1S/C27H35N3O6S.C25H33N3O4.C24H31N3O3.C23H29N3O3.C22H26N4O3.C22H25N3O5.C21H27N3O5S/c1-21(31)29-14-16-30(17-15-29)37(34,35)27-9-5-4-8-26(27)36-20-25(33)11-10-24(32)19-28-13-12-22-6-2-3-7-23(22)18-28;29-22(17-28-13-10-19-4-1-2-5-20(19)16-28)8-9-23(30)18-32-25-7-3-6-24(27-25)26-21-11-14-31-15-12-21;1-26-11-9-19-7-4-8-23(22(19)16-26)30-17-24(29)25-13-21(28)15-27-12-10-18-5-2-3-6-20(18)14-27;27-20(15-26-11-9-17-4-1-2-5-19(17)14-26)12-25-23(28)16-29-22-7-3-6-18-8-10-24-13-21(18)22;1-25-14-19-20(24-25)7-4-8-21(19)29-15-22(28)23-11-18(27)13-26-10-9-16-5-2-3-6-17(16)12-26;26-17(12-25-9-8-15-4-1-2-5-16(15)11-25)10-23-20(27)13-29-19-7-3-6-18-22(19)30-14-21(28)24-18;1-22-30(27,28)20-9-5-4-8-19(20)29-15-21(26)23-12-18(25)14-24-11-10-16-6-2-3-7-17(16)13-24/h2-9,24,32H,10-20H2,1H3;1-7,21-22,29H,8-18H2,(H,26,27);2-8,21,28H,9-17H2,1H3,(H,25,29);1-7,20,24,27H,8-16H2,(H,25,28);2-8,14,18,27H,9-13,15H2,1H3,(H,23,28);1-7,17,26H,8-14H2,(H,23,27)(H,24,28);2-9,18,22,25H,10-15H2,1H3,(H,23,26)
InChIKeyNXZXEEMIWYBOGQ-UHFFFAOYSA-N
XLogP10.27
TPSA617.97 Ų
H-Bond Donors16
H-Bond Acceptors42
Rotatable Bonds57
Heavy Atoms217
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003013.71
LogP ≤ 510.27
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1042

Analyze 1-[2-(4-acetylpiperazin-1-yl)sulfonylphenoxy]-6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxyhexan-2-one;6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxy-1-[[6-(oxan-4-ylamino)-2-pyridinyl]oxy]hexan-2-one;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(2-methyl-3,4-dihydro-1H-isoquinolin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(2-methylindazol-4-yl)oxyacetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[2-(methylsulfamoyl)phenoxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(3-oxo-4H-1,4-benzoxazin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(1,2,3,4-tetrahydroisoquinolin-8-yloxy)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[2-(4-acetylpiperazin-1-yl)sulfonylphenoxy]-6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxyhexan-2-one;6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxy-1-[[6-(oxan-4-ylamino)-2-pyridinyl]oxy]hexan-2-one;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(2-methyl-3,4-dihydro-1H-isoquinolin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(2-methylindazol-4-yl)oxyacetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[2-(methylsulfamoyl)phenoxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(3-oxo-4H-1,4-benzoxazin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(1,2,3,4-tetrahydroisoquinolin-8-yloxy)acetamide?
The IUPAC name of 1-[2-(4-acetylpiperazin-1-yl)sulfonylphenoxy]-6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxyhexan-2-one;6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxy-1-[[6-(oxan-4-ylamino)-2-pyridinyl]oxy]hexan-2-one;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(2-methyl-3,4-dihydro-1H-isoquinolin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(2-methylindazol-4-yl)oxyacetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[2-(methylsulfamoyl)phenoxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(3-oxo-4H-1,4-benzoxazin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(1,2,3,4-tetrahydroisoquinolin-8-yloxy)acetamide (CID 159917798) is 1-[2-(4-acetylpiperazin-1-yl)sulfonylphenoxy]-6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxyhexan-2-one;6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxy-1-[[6-(oxan-4-ylamino)-2-pyridinyl]oxy]hexan-2-one;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(2-methyl-3,4-dihydro-1H-isoquinolin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(2-methylindazol-4-yl)oxyacetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[2-(methylsulfamoyl)phenoxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(3-oxo-4H-1,4-benzoxazin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(1,2,3,4-tetrahydroisoquinolin-8-yloxy)acetamide.
What is the SMILES notation for 1-[2-(4-acetylpiperazin-1-yl)sulfonylphenoxy]-6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxyhexan-2-one;6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxy-1-[[6-(oxan-4-ylamino)-2-pyridinyl]oxy]hexan-2-one;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(2-methyl-3,4-dihydro-1H-isoquinolin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(2-methylindazol-4-yl)oxyacetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[2-(methylsulfamoyl)phenoxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(3-oxo-4H-1,4-benzoxazin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(1,2,3,4-tetrahydroisoquinolin-8-yloxy)acetamide?
The canonical SMILES for 1-[2-(4-acetylpiperazin-1-yl)sulfonylphenoxy]-6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxyhexan-2-one;6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxy-1-[[6-(oxan-4-ylamino)-2-pyridinyl]oxy]hexan-2-one;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(2-methyl-3,4-dihydro-1H-isoquinolin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(2-methylindazol-4-yl)oxyacetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[2-(methylsulfamoyl)phenoxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(3-oxo-4H-1,4-benzoxazin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(1,2,3,4-tetrahydroisoquinolin-8-yloxy)acetamide is CC(=O)N1CCN(S(=O)(=O)c2ccccc2OCC(=O)CCC(O)CN2CCc3ccccc3C2)CC1.CN1CCc2cccc(OCC(=O)NCC(O)CN3CCc4ccccc4C3)c2C1.CNS(=O)(=O)c1ccccc1OCC(=O)NCC(O)CN1CCc2ccccc2C1.Cn1cc2c(OCC(=O)NCC(O)CN3CCc4ccccc4C3)cccc2n1.O=C(CCC(O)CN1CCc2ccccc2C1)COc1cccc(NC2CCOCC2)n1.O=C(COc1cccc2c1CNCC2)NCC(O)CN1CCc2ccccc2C1.O=C(COc1cccc2c1OCC(=O)N2)NCC(O)CN1CCc2ccccc2C1.
What is the InChIKey of 1-[2-(4-acetylpiperazin-1-yl)sulfonylphenoxy]-6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxyhexan-2-one;6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxy-1-[[6-(oxan-4-ylamino)-2-pyridinyl]oxy]hexan-2-one;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(2-methyl-3,4-dihydro-1H-isoquinolin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(2-methylindazol-4-yl)oxyacetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[2-(methylsulfamoyl)phenoxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(3-oxo-4H-1,4-benzoxazin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(1,2,3,4-tetrahydroisoquinolin-8-yloxy)acetamide?
The InChIKey is NXZXEEMIWYBOGQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H35N3O6S.C25H33N3O4.C24H31N3O3.C23H29N3O3.C22H26N4O3.C22H25N3O5.C21H27N3O5S/c1-21(31)29-14-16-30(17-15-29)37(34,35)27-9-5-4-8-26(27)36-20-25(33)11-10-24(32)19-28-13-12-22-6-2-3-7-23(22)18-28;29-22(17-28-13-10-19-4-1-2-5-20(19)16-28)8-9-23(30)18-32-25-7-3-6-24(27-25)26-21-11-14-31-15-12-21;1-26-11-9-19-7-4-8-23(22(19)16-26)30-17-24(29)25-13-21(28)15-27-12-10-18-5-2-3-6-20(18)14-27;27-20(15-26-11-9-17-4-1-2-5-19(17)14-26)12-25-23(28)16-29-22-7-3-6-18-8-10-24-13-21(18)22;1-25-14-19-20(24-25)7-4-8-21(19)29-15-22(28)23-11-18(27)13-26-10-9-16-5-2-3-6-17(16)12-26;26-17(12-25-9-8-15-4-1-2-5-16(15)11-25)10-23-20(27)13-29-19-7-3-6-18-22(19)30-14-21(28)24-18;1-22-30(27,28)20-9-5-4-8-19(20)29-15-21(26)23-12-18(25)14-24-11-10-16-6-2-3-7-17(16)13-24/h2-9,24,32H,10-20H2,1H3;1-7,21-22,29H,8-18H2,(H,26,27);2-8,21,28H,9-17H2,1H3,(H,25,29);1-7,20,24,27H,8-16H2,(H,25,28);2-8,14,18,27H,9-13,15H2,1H3,(H,23,28);1-7,17,26H,8-14H2,(H,23,27)(H,24,28);2-9,18,22,25H,10-15H2,1H3,(H,23,26).
What are the key properties of 1-[2-(4-acetylpiperazin-1-yl)sulfonylphenoxy]-6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxyhexan-2-one;6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxy-1-[[6-(oxan-4-ylamino)-2-pyridinyl]oxy]hexan-2-one;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(2-methyl-3,4-dihydro-1H-isoquinolin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(2-methylindazol-4-yl)oxyacetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[2-(methylsulfamoyl)phenoxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(3-oxo-4H-1,4-benzoxazin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(1,2,3,4-tetrahydroisoquinolin-8-yloxy)acetamide?
1-[2-(4-acetylpiperazin-1-yl)sulfonylphenoxy]-6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxyhexan-2-one;6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxy-1-[[6-(oxan-4-ylamino)-2-pyridinyl]oxy]hexan-2-one;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(2-methyl-3,4-dihydro-1H-isoquinolin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(2-methylindazol-4-yl)oxyacetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[2-(methylsulfamoyl)phenoxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(3-oxo-4H-1,4-benzoxazin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(1,2,3,4-tetrahydroisoquinolin-8-yloxy)acetamide has a molecular weight of 3013.71 g/mol, XLogP of 10.27, 57 rotatable bonds, 16 hydrogen bond donors, and 42 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[2-(4-acetylpiperazin-1-yl)sulfonylphenoxy]-6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxyhexan-2-one;6-(3,4-dihydro-1H-isoquinolin-2-yl)-5-hydroxy-1-[[6-(oxan-4-ylamino)-2-pyridinyl]oxy]hexan-2-one;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(2-methyl-3,4-dihydro-1H-isoquinolin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(2-methylindazol-4-yl)oxyacetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[2-(methylsulfamoyl)phenoxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-[(3-oxo-4H-1,4-benzoxazin-8-yl)oxy]acetamide;N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-2-(1,2,3,4-tetrahydroisoquinolin-8-yloxy)acetamide is sourced from PubChem (CID 159917798), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).